Cargando…
Ceramides as Risk Markers for Future Cardiovascular Events and All-Cause Mortality in Long-standing Type 1 Diabetes
Ceramides are lipid molecules involved in inflammation-related signaling. Recent studies have shown that higher amounts of specific circulating ceramides and their ratios are associated with future development of cardiovascular (CV) disease (CVD). We examined the associations between serum ceramide...
Autores principales: | Wretlind, Asger, Curovic, Viktor R., Suvitaival, Tommi, Theilade, Simone, Tofte, Nete, Winther, Signe A., Vilsbøll, Tina, Vestergaard, Henrik, Rossing, Peter, Legido-Quigley, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545556/ https://www.ncbi.nlm.nih.gov/pubmed/37478203 http://dx.doi.org/10.2337/db23-0052 |
Ejemplares similares
-
Ceramides are decreased after liraglutide treatment in people with type 2 diabetes: a post hoc analysis of two randomized clinical trials
por: Wretlind, Asger, et al.
Publicado: (2023) -
Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial
por: Zobel, Emilie H, et al.
Publicado: (2021) -
Lipidomic analysis reveals sphingomyelin and phosphatidylcholine species associated with renal impairment and all-cause mortality in type 1 diabetes
por: Tofte, Nete, et al.
Publicado: (2019) -
Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetes
por: Ferreira-Divino, Luis F., et al.
Publicado: (2022) -
Cardiovascular autonomic neuropathy and the impact on progression of diabetic kidney disease in type 1 diabetes
por: Bjerre-Christensen, Theis, et al.
Publicado: (2021)